Qube Research & Technologies (QRT)’s INmune Bio INMB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66.5K	Buy	+40,773	New	+$56.4K	﹤0.01%	3085
2025 Q1	–	Sell	-13,298	Closed	-$62.1K	–	3674
2024 Q4	$62.1K	Buy	+13,298	New	+$69.3K	﹤0.01%	3070
2024 Q3	–	Sell	-3,384	Closed	-$29.8K	–	3698
2024 Q2	$29.8K	Sell	3,384 -40,781	-92%	-$402K	﹤0.01%	2831
2024 Q1	$519K	Buy	44,165 +14,728	+50%	+$178K	﹤0.01%	2517
2023 Q4	$331K	Buy	+29,437	New	+$247K	﹤0.01%	2530
2020 Q4	–	Sell	-23,981	Closed	-$247K	–	1993
2020 Q3	$247K	Buy	+23,981	New	+$244K	﹤0.01%	1321

Other funds holding INMB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INMB Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in INmune Bio (INMB) in Q2 2026: 40,773 shares worth $66.5K. The stake represents ﹤0.01% of the portfolio and ranks #3085 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in INMB as recently as Q4 2024.

Qube Research & Technologies (QRT) first reported a position in INMB in Q3 2020 and has held it in 6 quarters since. The position peaked at $519K in Q1 2024. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

Qube Research & Technologies (QRT) held 40,773 shares of INmune Bio worth $66.5K as of Q2 2026.
INmune Bio was a new Qube Research & Technologies (QRT) position in Q2 2026.
INmune Bio made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3085 holding.
Qube Research & Technologies (QRT) first reported a position in INmune Bio in Q3 2020 and has held it in 6 quarters since.
Qube Research & Technologies (QRT)'s INmune Bio position peaked at $519K in Q1 2024.
83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.